Background and objective COVID-19 neurological manifestations have been progressively
recognized. Among available MRI techniques, diffusion weighted imaging (DWI) shows …

BACKGROUND: Neurologic events have been reported in patients with coronavirus disease
2019 (COVID-19). However, a model-based evaluation of the spatial distribution of these …

Background Increasing evidence supported the possible neuro-invasion potential of SARS-
CoV-2. However, no studies were conducted to explore the existence of the micro-structural …

Background: The detailed extent of neuroinvasion or deleterious brain changes resulting
from COVID-19 and their time courses remain to be determined in relation to “long-haul” …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused several
outbreaks of highly contagious respiratory diseases worldwide. The respiratory symptoms of …

Neurological dysfunction has been reported to occur in up to 36.4% patients of coronavirus
disease-19 (COVID-19) and patients with severe infection are more likely to develop …

BACKGROUND The coronavirus disease 2019 (COVID-19) rapidly progressed to a global
pandemic. Although some patients totally recover from COVID-19 pneumonia, the disease's …

Coronavirus 2019 (COVID-19) is currently the center of what has become a public health
crisis. While the virus is well-known for its trademark effects on respiratory function …

There is mounting evidence of the long-term effects of COVID-19 on the central nervous
system, with patients experiencing diverse symptoms, often suggesting brain involvement …

Brain changes have been reported in the first weeks after SARS-CoV-2 infection. However,
limited literature exists about brain alterations in post-COVID syndrome, a condition …